NKX3-2 Gene Spondylo-Megaepiphyseal-Metaphyseal Dysplasia Genetic Test sale cost 4400 AED
DYNC2H1 Gene Short-Rib Thoracic Dysplasia Type 3 with or Without Polydactyly Genetic Test sale cost 4400 AED DYNC2H1 Gene Short-Rib Thoracic Dysplasia Type 3 with or Without Polydactyly Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MED13L Gene Transposition of the Great Arteries Dextro-Looped 1 Genetic Test sale cost 4400 AED MED13L Gene Transposition of the Great Arteries Dextro-Looped 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NKX3-2 Gene Spondylo-Megaepiphyseal-Metaphyseal Dysplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NKX3-2 Gene Spondylo-Megaepiphyseal-Metaphyseal Dysplasia (SMMD) Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the NKX3-2 gene, which are responsible for causing SMMD. This rare genetic disorder is characterized by various skeletal anomalies, including abnormalities in the vertebrae, large epiphyses, and metaphyseal changes. Individuals affected by SMMD may exhibit short stature, joint pain, and limited mobility among other symptoms.

Conducted at DNA Labs UAE, this test is crucial for the accurate diagnosis of SMMD, enabling healthcare providers to tailor treatment and management plans to the specific needs of the patient. The test involves collecting a DNA sample, usually through a blood draw, which is then analyzed for the presence of mutations in the NKX3-2 gene.

The cost of the NKX3-2 Gene Spondylo-Megaepiphyseal-Metaphyseal Dysplasia Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the genetic analysis and the expertise required to interpret the results. Given the rarity and complexity of SMMD, this test represents a significant step forward in providing targeted care for individuals with this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia Genetic Test

Cost: 4400.0 AED

Test Name: NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia NGS Genetic DNA Test gene NKX3-2

Test Details:

The NKX3-2 gene is associated with a rare genetic disorder called spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD). SMMD is characterized by abnormal bone development, particularly in the spine (spondylo), large growth plates at the ends of long bones (megaepiphyseal), and the region between the growth plate and the shaft of the bone (metaphyseal).

NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology. It allows for the rapid sequencing of a large number of genes simultaneously. In the context of SMMD, NGS genetic testing can be used to identify mutations or variations in the NKX3-2 gene that may be responsible for the condition. By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic changes that may be causing SMMD. This information can help with diagnosis, prognosis, and potentially guide treatment options for individuals affected by this condition.

Test Name NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NKX3-2 Gene Spondylo-megaepiphyseal-metaphyseal dysplasia NGS Genetic DNA Test gene NKX3-2
Test Details

The NKX3-2 gene is associated with a rare genetic disorder called spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD). SMMD is characterized by abnormal bone development, particularly in the spine (spondylo), large growth plates at the ends of long bones (megaepiphyseal), and the region between the growth plate and the shaft of the bone (metaphyseal).

NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology. It allows for the rapid sequencing of a large number of genes simultaneously. In the context of SMMD, NGS genetic testing can be used to identify mutations or variations in the NKX3-2 gene that may be responsible for the condition.

By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic changes that may be causing SMMD. This information can help with diagnosis, prognosis, and potentially guide treatment options for individuals affected by this condition.

SKU: TEST-4393 Category:

Related products